Antibiotic discovery with artificial intelligence for the treatment of Acinetobacter baumannii infections
mSystems · 18.06.2024 · 9 (6)
DOI: 10.1128/msystems.00325-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSystems, erschienen am 18.06.2024. Verfasst von Yassir Boulaamane und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Innovative Technologies, National School of Applied Sciences of Tangier, Abdelmalek Essaadi University, Tetouan, Morocco. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Anti-Bacterial Agents, Acinetobacter Infections, Artificial Intelligence. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejería de Universidad, Investigación e Innovación de la Junta de Andalucía, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Global challenges presented by multidrug-resistant Acinetobacter baumannii infections have stimulated the development of new treatment strategies. We reported that outer membrane protein W (OmpW) is a potential therapeutic target in A. baumannii . Here, a library of 11,648 natural compounds was subjected to a primary screening using quantitative structure-activity relationship (QSAR) models generated from a ChEMBL data set with >7,000 compounds with their reported minimal inhibitory concentration (MIC) values against A. baumannii followed by a structure-based virtual screening against OmpW. In silico pharmacokinetic evaluation was conducted to assess the drug-likeness of these compounds. The ten highest-ranking compounds were found to bind with an energy score ranging from −7.8 to −7.0 kcal/mol where most of them belonged to curcuminoids. To validate these findings, one lead compound exhibiting promising binding stability as well as favorable pharmacokinetics properties, namely demethoxycurcumin, was tested against a panel of A. baumannii strains to determine its antibacterial activity using microdilution and time-kill curve assays. To validate whether the compound binds to the selected target, an OmpW-deficient mutant was studied and compared with the wild type. Our results demonstrate that demethoxycurcumin in monotherapy and in combination with colistin is active against all A. baumannii strains. Finally, the compound was found to significantly reduce the A. baumannii interaction with host cells, suggesting its anti-virulence properties. Collectively, this study demonstrates machine learning as a promising strategy for the discovery of curcuminoids as antimicrobial agents for combating A. baumannii infections. IMPORTANCE Acinetobacter baumannii presents a severe global health threat, with alarming levels of antimicrobial resistance rates resulting in significant morbidity and mortality in the USA, ranging from 26% to 68%, as reported by the Centers for Disease Control and Prevention (CDC). To address this threat, novel strategies beyond traditional antibiotics are imperative. Computational approaches, such as QSAR models leverage molecular structures to predict biological effects, expediting drug discovery. We identified OmpW as a potential therapeutic target in A. baumannii and screened 11,648 natural compounds. We employed QSAR models from a ChEMBL bioactivity data set and conducted structure-based virtual screening against OmpW. Demethoxycurcumin, a lead compound, exhibited promising antibacterial activity against A. baumannii , including multidrug-resistant strains. Additionally, demethoxycurcumin demonstrated anti-virulence properties by reducing A. baumannii interaction with host cells. The findings highlight the potential of artificial intelligence in discovering curcuminoids as effective antimicrobial agents against A. baumannii infections, offering a promising strategy to address antibiotic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Innovative Technologies, National School of Applied Sciences of Tangier, Abdelmalek Essaadi University, Tetouan, Morocco.
- Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide/CSIC/Junta de Andalucía, Seville, Spain.
- Departamento de Biología Molecular e Ingeniería Bioquímica, Universidad Pablo de Olavide, Seville, Spain.
- Biosanitary Research Institute (IIB-VIU), Valencian International University (VIU), Valencia, Spain.
- Bioinformatics Laboratory, College of Computing, Mohammed VI Polytechnic University, Benguerir, Morocco.
- Faculty of Sciences and Techniques of Tangier, Abdelmalek Essaadi University, Tetouan, Morocco.
ORCID-Profile: Abdelkrim Hmadcha, Younes Smani
Förderung
- Consejería de Universidad, Investigación e Innovación de la Junta de Andalucía
- Instituto de Salud Carlos III
Zitieren
APA
Boulaamane, Y., Molina Panadero, I., Hmadcha, A., Atalaya Rey, C., Baammi, S., El Allali, A., Maurady, A., & Smani, Y. (2024). Antibiotic discovery with artificial intelligence for the treatment of Acinetobacter baumannii infections. mSystems, 9(6). https://doi.org/10.1128/msystems.00325-24
Vancouver
Boulaamane Y, Molina Panadero I, Hmadcha A, Atalaya Rey C, Baammi S, El Allali A, et al. Antibiotic discovery with artificial intelligence for the treatment of Acinetobacter baumannii infections. mSystems. 2024;9(6). doi:10.1128/msystems.00325-24
BibTeX
@article{Boulaamane2024,
author = {Boulaamane, Yassir and Molina Panadero, Irene and Hmadcha, Abdelkrim and Atalaya Rey, Celia and Baammi, Soukayna and El Allali, Achraf and Maurady, Amal and Smani, Younes},
title = {Antibiotic discovery with artificial intelligence for the treatment of Acinetobacter baumannii infections},
journal = {mSystems},
year = {2024},
volume = {9},
number = {6},
doi = {10.1128/msystems.00325-24}
}
EUVIMED